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Peptides derived from the unprocessed N-termini of mouse and bovine prion proteins (mPrPp and bPrPp, respectively), comprising
hydrophobic signal sequences followed by charged domains (KKRPKP), function as cell-penetrating peptides (CPPs) with live cells,
concomitantly causing toxicity. Using steady-state fluorescence techniques, including calcein leakage and polarization of a membrane probe
(diphenylhexatriene, DPH), as well as circular dichroism, we studied the membrane interactions of the peptides with large unilamellar
phospholipid vesicles (LUVs), generally with a 30% negative surface charged density, comparing the effects with those of the CPP penetratin
(pAntp) and the pore-forming peptide melittin. The prion peptides caused significant calcein leakage from LUVs concomitant with increased
membrane ordering. Fluorescence correlation spectroscopy (FCS) studies of either rhodamine-entrapping (REVs) or rhodamine-labeled (RLVs)
vesicles, showed that addition of the prion peptides resulted in significant release of rhodamine from the REVs without affecting the overall
integrity of the RLVs. The membrane leakage effects due to the peptides had the following order of potency: melittin>mPrPp>bPrPp>pAntp.
The membrane perturbation effects of the N-terminal prion peptides suggest that they form transient pores (similar to melittin) causing toxicity in
parallel with their cellular trafficking.
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Abbreviations: PrP, prion protein; PrPC, cellular isoform of PrP; PrPSc,
scrapie isoform of PrP; mPrPp, peptide with sequence corresponding to the N-
terminus of the mouse prion protein, residues 1–28; bPrPp, peptide with
sequence corresponding to the N-terminus of the bovine prion protein, residues
1–30; NLS, nuclear localization sequence; CPP, cell-penetrating peptide;
pAntp, penetratin, Antennapedia homeodomain-derived CPP; ER, endoplasmic
reticulum; DHPC, 1,2-dihexanoyl-sn-glycero-3-phosphatidylcholine; POPC, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoglycerol; POPG/POPC, [30/70] notation refers to vesicles
with 30 mol% POPG content; SUVs, small unilamellar vesicles; LUVs, large
unilamellar vesicles; Rh, rhodamine; REVs, Rh-entrapping LUVs; RLVs, Rh-
labeled LUVs; FCS, fluorescence correlation spectroscopy; CD, circular
dichroism; DPH, diphenylhexatriene, membrane bound fluorescence probe;
P/L, total peptide-to-phospholipid molar ratio
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Prion diseases, also known as transmissible spongiform
encephalopathies, are fatal neurological disorders of humans
and animals that appear in sporadic, familial and infectiously
acquired forms. These disorders are caused by conversion of a
normal neuronal glycoprotein (PrPC) into an infectious,
conformationally altered isoform (PrPSc) [1–3].
The conversion of PrPC into PrPSc occurs via a post-
translational process [4]. PrPC is monomeric and readily
digested by proteinase K, whereas PrPSc forms insoluble
aggregates and shows a high resistance to proteolytic digestion
[5]. The characteristics of the two forms of the prion protein
(PrP) can be related to their differences in secondary structure.
PrPC adopts a predominantly a-helical structure in its globular
C-terminal half, and its N-terminus is largely unstructured [6],
whereas PrPSc has a large content of h-sheet secondary
structure [7].1716 (2005) 126 – 136
http://www
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topologies during biogenesis at the ER membrane [8–12].
Most PrPC molecules are fully translocated into the lumen of
the ER; this form, denoted SecPrP, is eventually attached to the
outer leaflet of the plasma membrane through a C-terminal
glycosylphosphatidylinositol (GPI) anchor. Some PrPC mole-
cules assume transmembrane orientations. These forms, desig-
nated CtmPrP and NtmPrP, span the ER lipid bilayer once, either
with the C- or N-terminus, respectively, on the lumenal side of
the ER.
The signal sequence of SecPrP is normally cleaved by a signal
peptidase that acts in the lumen of the ER. However, in a recent
study, it has been shown that in neuronal cells, the SecPrP form
retains its N-terminal signal sequence following its exit from the
ER and during its trafficking to the cell surface [11]. It has also
been reported that CtmPrP is unprocessed and contains an
uncleaved N-terminal signal peptide [13]. The signal sequence
appears to have an unusual role in prion proteins in that it has
two separate functions, both targeting and topogenesis [13–15].
It has also been suggested that CtmPrP is associated with the
neurodegeneration observed in prion disease [9]. Another
variant of PrP discussed as a neurotoxic intermediate is
cytosolic PrP, CytPr, which also sometimes retains the signal
peptide [16–18]. Hence, even if the situations where unpro-
cessed prion proteins appear may be relatively rare, these
situations may be important for a pathological process.
Previously, we have investigated certain properties of the N-
termini of the unprocessed mouse (residues 1–28) and bovine
(residues 1–30) PrPs, denoted mPrPp [19] and bPrPp [20],
respectively. These sequences (Table 1) comprise the signal
peptide (residues 1–22 for mPrPp, residues 1–24 for bPrPp)
and an identical and highly positively charged, NLS-like,
sequence (residues 23–28 for mPrPp, residues 25–30 for
bPrPp). The mPrPp and bPrPp sequences are similar to those of
certain chimeric cell-penetrating peptides (CPPs), and we
found that mPrPp and bPrPp can indeed function as CPPs
([21], and Magzoub et al., unpublished results). CPPs are able
to translocate into various cells, carrying a conjugated
hydrophilic macromolecular Fcargo_ [21,22]. Recent observa-
tions on CPP entry into cells emphasize the role of heparan
sulphate as a mediator of raft-dependent macropinocytosis, a
particular form of endocytosis [23,24]. Cellular heparan
sulphate has also been shown to interact with prion proteins
[25], and PrPSc incorporation into CHO cells requires
glycosaminoglycan expression [26]. The interaction of various
forms of PrP with model membranes have also been
investigated [27,28].Table 1
The origin and amino acid sequences of the four peptides studieda
Peptide Origin Sequence
pAntp Homeodomain (Drosophila) RQIKIWF
mPrPp N-terminus of mouse prion protein (residues 1 to 28) MANLGY
bPrPp N-terminus of bovine prion protein (residues 1 to 30) MVKSKI
Melittin Honeybee venom (Apis mellifera) GIGAVLK
a Given are also the net charges of the peptides, as well as their average hydroph
b The average hydrophobicity of the peptides is calculated using the scale deviseIn the present study, we have studied the interactions of
mPrPp and bPrPp with large unilamellar phospholipids vesicles
(LUVs) of varying surface charge densities, using fluorescence
and CD spectroscopic methods. The membrane interaction
effects of the two prion peptides were compared with those of
two well-characterized peptides: the CPP penetratin (pAntp),
and the pore-forming peptide melittin (Table 1). The steady-
state fluorescence studies were complemented by fluorescence
correlation spectroscopy (FCS) studies. FCS gives information
on the translational diffusion of fluorescent particles with high
specificity [29].
2. Materials and methods
2.1. Materials
The prion peptides and pAntp were produced by Neosystem Laboratoire,
Strasbourg. Peptides were used as purchased. The identity and purity were
controlled by amino acid, mass spectral and HPLC analyses. Peptides were of
Immunograde quality (purity estimated at ¨80%). In each case, peptides from
more than one batch were used. Melittin from the venom of honeybee (Apis
mellifera) was obtained from Sigma. 1-palmitoyl-2-oleoyl-phosphatidylcholine
(POPC), and 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG), were pur-
chased from Avanti Polar Lipids, Alabaster, of the best quality, and were used
without further purification. Diphenylhexatriene (DPH) was obtained from
Sigma. Rh (tetramethylrhodamine-5,6-isothiocyanate) and Rh-PE (6-tetra-
methylrhodamine-1,2-dihexadecanoyl-3-phosphoethanolamine) were pur-
chased from Molecular Probes, The Netherlands. Calcein, a fluorescein
derivative, was also purchased from Molecular Probes (product no. C-481).
2.2. Determination of peptide concentrations
After weighing on a microbalance, the peptide concentrations in the stock
solutions were determined by light absorption on a CARY 4 Spectrophotom-
eter, using quartz cuvettes with a 1-cm light path. All spectra were baseline
corrected. Molar absorptivities of 5690 and 1280 M1 cm1, at 280 nm, for
tryptophan and tyrosine, respectively, were applied.
2.3. Sample preparations
2.3.1. Preparation of LUVs
Large unilamellar vesicles were prepared by initially dissolving the
phospholipids at the desired concentration (with the chosen POPG/POPC
molar ratio) in a chloroform/ethanol mixture, to ensure complete mixing of the
components, and then removing the solvent by placing the sample in a high
vacuum for 3 h. The dried lipids were dispersed in 50 mM potassium phosphate
buffer (pH 7.4). The dispersion was run through a freeze– thaw cycle five times
and then passed through two polycarbonate filters (0.1 Am pore size) 20 times
in an Avanti manual extruder.
2.3.2. Preparation of REVs and RLVs
To prepare the Rh-entrapping LUVs (REVs), prior to extrusion, the dried
lipid film (prepared as described above) was dispersed in 50 mM potassiumNet charge Hydrophobicityb
QNRRMKWKK +7 1.7
WLLALFVTMWTDVGLC KKRPKP +3 0.3
GSWILVLFVAMWSDVGLCKKRPKP +5 0.4
VLTTGLPALISWIKRKRQQ +5 0.3
obicities. The charged residues are underlined.
d by Kyte and Doolittle [60].
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dissolved Rh, which can be released if pore/channels are formed into the
vesicles, or if the vesicles are broken. A Rh concentration gradient was created
by diluting the REV samples 100- to 200-fold in the buffer, resulting in a less
than 1 nM background Rh concentration outside the vesicles.
To prepare the Rh-labeled LUVs (RLVs), the phospholipids, including 0.1
mol% Rh-labeled lipids, were dissolved in the chloroform/ethanol mixture prior
to making the lipid film. Rh is covalently bound to the head-groups of the
phosphatidylethanolamine, and only the disintegration of the RLVs can lead to
the appearance of faster diffusing Rh in solution.
2.4. Steady-state fluorescence spectroscopy
Fluorescence was measured on a Perkin Elmer LS 50B Luminescence
Spectrometer with FL WinLab software. Measurements were made in 410
mm quartz cuvettes at 20 -C. For DPH experiments the excitation was at 340
nm and the emission wavelength scanned from 400 to 550 nm. Calcein was
excited at 490 nm and the emission scanned from 510 to 600 nm. Scans were
usually recorded with 4 nm excitation and emission bandwidths and a scan
speed of 250 nm/min. 3 scans were recorded and averaged for each sample.
2.4.1. Peptide-induced calcein release
LUVs with entrapped calcein were prepared by hydrating a lipid film of
desired composition with 70 mM calcein present in the buffer (the final pH was
adjusted to 7.4 by the addition of NaOH from a 10-M stock solution). The
fluorescence from calcein at 70 mM was low due to self-quenching, but
increased considerably upon dilution. Free calcein was separated from the
LUVs on a Sephadex-G25 column. Increasing concentrations of peptides were
added (from a 1-mM stock solution) to LUVs composed of 250 AM
phospholipid mixtures of different POPG/POPC content. After 5-min
incubation, release of calcein from the LUVs was monitored by an increase
in the fluorescence intensity.
The maximum fluorescence intensity corresponding to 100% leakage was
determined by lysing the vesicles with 10% (w/v) Triton X-100. The % leakage
was then calculated according to the following equation:
% leakage¼ 100 FF0
FmaxF0

ð1Þ
where F0 represents the fluorescence intensity of the intact vesicles, F and Fmax
the intensity before and after the addition of the detergent, respectively.
2.4.2. Fluorescence polarization
LUVs were labeled with the membrane-bound probe diphenylhexatriene
(DPH). 2 AM DPH (from a 1 mM ethanolic stock solution) was added to LUVs
composed of 200 AM phospholipid mixtures of different POPG/POPC content.
The samples were allowed to equilibrate for 15 min before measurement.
Increasing concentrations of peptides, from a 1-mM stock solution, were added
to the labeled LUV samples, and allowed to stand for 10 min. A polarization
attachment (Shimadzu) was adapted to the spectrometer. The steady-state
polarization was determined using the following equation [30]:
P¼ IVVGIVH
IVVþGIVH ð2Þ
where IVV is the emission intensity of vertically polarized light parallel to the
plane of excitation and IVH is the emission intensity of horizontally polarized
light perpendicular to the plane of excitation. The instrumental factor G
(G = IHV/IHH) was determined by measuring the polarized components of
fluorescence of the probe with horizontally polarized excitation.
2.5. Fluorescence correlation spectroscopy (FCS)
2.5.1. FCS instrumentation
FCS was performed with confocal illumination of a volume element of 0.2
fl in an instrument as described previously [31,32]. As focusing optics a Zeiss
Neofluar 63NA 1.2 was used in an epi-illumination setup. For separating
exciting from emitted radiation a dichroic filter (Omega 540 DRL PO2) and a
bandpass filter (Omega 565 DR 50) were used. REVs or RLVs were excited
with the 514.5-nm line of an Argon laser. The fluorescence intensityfluctuations were detected by an avalanche photo diode (EG and SPCM 200)
and were correlated with a digital correlator (ALV 5000, ALV, Langen,
Germany).
2.5.2. FCS data evaluation
The observed fluorescence intensity fluctuations dI(t) when correlated with
fluorescence intensity fluctuations at time t +s yield the normalized intensity
autocorrelation function G(s):
G sð Þ ¼ 1þ bdI tð ÞsI t þ sð Þ
bI2
ð3Þ
where the brackets describe the time average and I the mean fluorescence
intensity [33,34].
The intensity autocorrelation function G(s) for Brownian motion of
molecules/particles in a 3D Gaussian volume element is described [35] as
follows:
G sð Þ ¼ 1þ 1
N
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where sD is the characteristic translational diffusion time related to the diffusion
coefficient D : sD ¼ x
2
4D
ð4bÞ
and N is the total number of detected fluorescence molecules, x (0.5 Am) is the
radius, and z (2 Am) the length of the volume element of the laser beam.
The expressions for the intensity autocorrelation function G(s) (Eqs. (3)
(4a) (4b)) are valid when the particle size is smaller than the volume element.
With a volume element of a diameter of 1 Am and a vesicle size of 0.1 Am this
condition is fulfilled. To calculate the average number of fluorophores per
volume element (N), and diffusion coefficients of free Rh (DF) and labeled
vesicles (DV), the intensity autocorrelation function G(s) is analyzed as
follows:
G sð Þ ¼ 1þ 1
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where N is the total number of fluorophores, sDv=x
2/4Dv is the diffusion time
for vesicles, sDF=x
2/4DF is the diffusion time for free Rh, y is the fraction of
Rh diffusing with the vesicles having the characteristic diffusion time sDv, and
(1y) is the fraction of free Rh diffusing with sDF. For parametrization and
fitting of the autocorrelation function G(s), a non-linear least squares
minimization procedure according to the Marquardt algorithm [36] was used.
2.5.3. FCS experiments
Free Rh was used as a reference to calibrate the instrument and to estimate
diffusion times of the RLVs, as well as to observe whether the vesicles are
intact or destroyed. The diffusion times of free Rh and RLVs were determined
separately. The effect of the peptides on vesicles was investigated by incubating
the vesicles together with the peptides. The total peptide-to-phospholipid molar
ratio (P/L) ratio varied from 0.05 to 0.1. 20 Al of the samples were analyzed for
30 s up to 10 min in the FCS instrument, at several time points of incubation,
ranging from minutes to hours. All experiments were performed at 20 -C.
2.6. Circular dichroism spectroscopy (CD)
CD measurements were made on a Jasco J-720 CD spectropolarimeter with
0.5 and 1 mm quartz cuvettes. Spectra were measured from 190 to 250 nm,
with a 0.2-nm step resolution at 50 nm/min speed. The response time was 2 s,
Fig. 1. Calcein leakage from LUVs, induced by the peptides: mPrPp (r), bPrPp
(4), pAntp (.) and melittin (˝). Increasing concentrations of the peptides were
added to LUV samples, composed of 250 AM phospholipid of different POPG/
POPC content. The LUVs had 70 mM calcein entrapped in the beginning. The
samples contained (a) POPC or (b) POPG/POPC [30/70]. The % calcein release
was plotted as a function of total peptide-to-lipid molar ratio, P/L. The medium
was 50 mM phosphate buffer (pH 7.4). The spectra were recorded at an ambient
temperature (20 -C). Inset: time-dependence of calcein leakage due to addition
of peptides at P/L=0.05.
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by a PTC-343 controller, set at 20 -C. Spectra were collected and averaged over
20 scans. Contributions from background signals were subtracted from the CD
spectra acquired for the peptide. Computer fittings using the VARSELEC
program [37], with 3 reference component spectra (a-helix, h-sheet and
random coil, r.c.) were performed to estimate the contributions of spectral
components from different secondary structures. The percentages describing
the contributions are precise within 5–10%.
3. Results
Table 1 shows the sequences of the mouse and bovine prion
peptides (mPrPp and bPrPp, respectively), as well as the two
archetypal peptides (pAntp and melittin). The pAntp sequence
corresponds to the 16 residues of the third a-helix of the
Antennapedia homeodomain protein from Drosophila and is a
well-known CPP [21]. Melittin is a 26-residue peptide derived
from honeybee venom, and is a well-known pore-forming
peptide [38].
3.1. Peptide-induced calcein release from LUVs
The membrane-perturbing effects of the peptides were
investigated through calcein-release experiments in LUVs.
The calcein-release assay is based on a high concentration (up
to 70 mM) of entrapped calcein, resulting in self-quenching of
its fluorescence. The degree of leakage of the vesicles induced
by the peptides is assessed by observing increased fluorescence
from the released calcein.
Fig. 1a shows the % leakage induced by the peptides with
neutral POPC LUVs, after 5 min exposure, at 20 -C. A study of
the time-dependence of calcein leakage from LUVs (Fig. 1b,
inset) indicated that the process is a relaxation towards an
equilibrium, and has a duration of approximately 5 min, after
which no further leakage takes place. Thus, the levels of leakage
presented in Fig. 1 should represent the final stage at each
peptide concentration. The results are summarized in Table 2.
pAntp, which does not interact with neutral membranes
[39,40], induced no leakage. Addition of bPrPp or mPrPp to
the neutral LUVs results in substantial degrees of leakage, 40%
and 66%, respectively. The leakage by the prion peptides
occurs at low peptide concentrations, where maximum leakage
is achieved at P/L ¨0.1, corresponding to 25 AM peptide.
Melittin was found to be far more potent: approximately 100%
leakage was induced already at P/L ¨0.02.
The leakage from charged POPG/POPC [30/70] LUVs
induced by the peptides is shown in Fig. 1b (results are
summarized in Table 2). Although pAntp does interact with
the charged vesicles [40], there is relatively little leakage effect.
bPrPp and mPrPp cause higher degrees of leakage, 54% and
74%, respectively, which are higher degrees of leakage than with
the neutral LUVs. Melittin gives 100% leakage, at a somewhat
higher P/L ¨003, as compared with the POPC LUVs.
3.2. DPH fluorescence polarization
The perturbation effects of the peptides on the membrane
properties of LUVs were studied by steady-state fluorescencepolarization of the DPH probe. When added to a membrane
suspension, DPH dissolves completely into the bilayer core,
with no significant emission in the aqueous phase. Since DPH
is buried deeply within the acyl chain region of the bilayer, any
increase in polarization reports on decreased acyl chain
mobility [41,42].
Fig. 2a shows the effect of addition of the peptides to
neutral POPC LUVs on the DPH polarization. Due to lack of
binding [39], pAntp does not significantly affect the DPH
polarization of the neutral vesicles. mPrPp and bPrPp, which
are hydrophobic enough to bind to neutral membranes,
increase the DPH polarization, with mPrPp inducing a greater
increase in membrane ordering than bPrPp. Melittin, causes a
slight decrease in the polarization, indicating that melittin
decreases the membrane ordering, leading to greater fluidity
Table 2
Summary of membrane activities and secondary structures of the peptidesa
Peptide Medium Secondary structure component (%) (P/L=0.04) Polarization D(P)
(P/L=0.1)
% calcein release
(P/L=0.1)a b r.c.
pAntp Water 13 24 62 – –
Buffer 14 25 60 – –
POPC 14 22 63 0 2
[30/70] 33 24 42 0 9
POPG 19 48 33 0.05 50
bPrPp Water 15 25 59 – –
Buffer 25 34 41 – –
POPC 28 39 31 0.01 40
[30/70] 11 55 32 0.06 54
mPrPp Water 18 26 56 – –
Buffer 24 32 44 – –
POPC 30 36 33 0.03 66
[30/70] 15 51 34 0.07 74
Melittin Water 16 15 67 – –
Buffer 28 11 60 – –
POPC 58 22 20 0.02 100
[30/70] 60 24 16 0.05 100
a Given are the changes in polarization (DP) and the % calcein release in the presence of LUVs with different compositions, at P/L ¨0.1. Also included are the
secondary structures induced in the peptides in the presence of distilled water and 50 mM phosphate buffer, pH 7.4, as well as the LUVs under conditions where the
two prion peptides are fully bound.
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agreement with a published study in which melittin was
found to induce lipid flip-flop in neutral, but not charged,
LUVs [43].
The effect of the peptides on charged LUVs from POPG/
POPC [30/70] is shown in Fig. 2b. pAntp induces no significant
change in the DPH fluorescence polarization. This is probably
due to the location of pAntp at the membrane surface, within the
headgroup region [40,44]. The prion peptides cause a consid-
erable increase in the DPH polarization, with mPrPp inducing a
slightly higher increase than bPrPp. The interaction of melittin
with the charged LUVs, unlike with the neutral ones, resulted in
a small increase in the DPH polarization.
Table 2 includes estimated changes (+/) in the DPH
polarization (DP) values induced by the four peptides at an
arbitrary P/L=0.1, with POPC and POPC/POPG [30/70]
LUVs. The leakage effects for mPrPp, bPrPp and pAntp
mirror their polarization influences: an increased LUV surface
charge density results in a greater degree of polarization and a
higher degree of leakage induced by the peptides. The effects
are more pronounced for melittin, followed by the prion
peptides.
3.3. FCS
In FCS measurements, the fluorescence intensity fluctua-
tions are recorded only from the molecules that diffuse
through the confocal laser volume element. The time
required for the passage of molecules through the volume
element is determined by the diffusion coefficient, related to
the size and shape of molecules. From the autocorrelation
functions of fluorescence intensity fluctuations, the average
number (N) and the diffusion time (sD) of fluorescent
molecules or particles crossing the confocal volume are
determined.3.3.1. FCS parameters
Fluorescence intensity autocorrelation functions, G(s), of
free Rh, POPG/POPC [30/70] REVs and RLVs (i.e. LUVs with
30% POPG content) are shown in Fig. 3a–c, respectively. In
the REV preparation, the Rh concentrations inside and outside
the vesicles were 200 nM and 2 nM, respectively. Table 3
summarizes the evaluated values of sD in each case. A two-
component analysis of the autocorrelation curves was used to
yield a slowly diffusing bound component (Rh diffusing with
the LUVs) and a fast moving non-bound one (freely diffusing
Rh). The diffusion time of free Rh in solution is 0.070T0.002
ms. The major component of the diffusion time of the REVs
(where the entrapped Rh diffuses with the vesicles) is 7.4T1
ms; a minor component (15%) has the sD of free Rh
(interpreted as the contribution from the free fraction of Rh).
The sD calculated for the RLVs id 8.4T1 ms. Due to the
large difference in diffusion times between free Rh and
vesicles, the fractions of Rh free in solution and diffusing
with the vesicles (either entrapped or covalently-bound), can be
seen separately and comparative observations can be made.
However, absolute quantifications of Rh release are not reliable
due to the large difference in fluorescence intensities between
Rh-entrapping vesicles and free Rh—the so-called Fbrightness
ratio_—which distorts the quantification (cf. [45]). In addition,
the tendency of Rh to bind to the surface of vesicles
(Rh+LUVs, Table 3) further contributes to the uncertainty
concerning the precise quantification of release of entrapped
Rh.
3.3.2. Effect of peptides on RLVs
Addition of melittin to POPG/POPC [30/70] RLVs, at P/
L=0.05, and mPrPp, bPrPp or pAntp at P/L=0.1, results in no
change in the RLV diffusion time (8.4T1 ms, Table 3),
showing that there is no free Rh in solution and that the LUVs
are intact. At the chosen P/L (0.1) for these studies both mPrPp
Fig. 2. Change in the fluorescence polarization of DPH labeled LUVs upon
addition of the peptides: mPrPp (r), bPrPp (4), pAntp (.) and melittin (˝).
The LUVs were composed of 250 AM phospholipid samples of different
POPG/POPC content, and containing 2 AM DPH. The LUV samples contained
(a) POPC or (b) POPG/POPC [30/70]. The polarization was plotted as a
function of P/L. 50 mM phosphate buffer medium (pH 7.4) was used. The
spectra were recorded at an ambient temperature.
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changes in fluorescence intensity of the intrinsic tryptophan
due to addition of vesicles (data not shown). This particular P/L
was also chosen since it allows a near maximum effect of these
peptides on the vesicles to be observed, while avoiding artifacts
such as LUV aggregation (data not shown).
3.3.3. Peptide-induced Rh release from REVs
FCS was used to monitor the release of entrapped Rh (200
nM) from REVs due to the peptides. Upon the addition of
melittin to the REVs (Fig. 3d), at a total peptide-to-phospho-
lipid molar ratio (P/L)=0.05, the evaluated fraction of free Rh
increases from 15% to approx. 80% (Table 3), indicating that
addition of melittin results in release of Rh from the REVs, in
agreement with previous studies [46,47].
Addition of the two prion peptides, mPrPp and bPrPp (Fig.
3e and f, respectively), at P/L=0.10, results in an increase in
the total fraction of free Rh to 70% and 65%, respectively
(Table 3), illustrating also for these peptides the release of Rhfrom the REVs. Exposure of the REVs to pAntp (P/L=0.1)
results in a small increase in the total free fraction to ¨20%,
indicating a weak effect of the peptide, possibly due to release
of peptide associated with the outside of the vesicle (Table 3).
Values of the number of diffusing particles N are included in
Table 3. The value of N increases from ¨0.3 for REVs alone to
¨2.8 upon addition of melittin, indicating an increase in the
number of fluorophores in solution. With the prion peptides the
value of N again increases, but to a lesser extent than with
melittin (N ¨1.3 and 1.1 for mPrPp and bPrPp, respectively).
No change in the value of N is observed upon addition of
pAntp. This confirms the increase in apparent fraction of free
Rh upon addition of melittin and the prion peptides to the
REVs inferred from the sD observations.
Lysing the LUVs with Triton X-100 (10% w/v) results in a
¨65% fraction of freely diffusing Rh, with sD ¨0.07 ms (data
not shown). The remainder has a sD of 0.5 ms, indicating
complex formation between Rh and phospholipids (micelles).
Incubation of non-labeled LUVs with free Rh results in a
fraction of the Rh (¨30%) diffusing with the LUVs (sD=7.4
ms), while the value of N decreases from 3.2 to 2.4, which
confirms the affinity of Rh for lipids (Table 3). Taken together,
the FCS results with melittin and the prion peptides indicate
that under conditions where leakage of vesicle content is
observed, the overall integrity of the vesicle is intact.
3.4. Peptide secondary structures
The secondary structures induced in the peptides in the
presence of water, buffer and LUVs of different lipid
compositions, were studied by CD spectroscopy (Fig. 4). In
all experiments the peptide concentration was 4 AM, and the
phospholipid concentration was 100 A (P/L=0.04). Under these
conditions, the prion peptides were found to be in the fully
membrane bound state, verified by fluorescence experiments
(data not shown). Table 2 summarizes the secondary structure
contributions of the peptides evaluated for the various solvents.
Although structure analysis of peptides by CD is at best
approximate, significant trends are seen. In distilled water, all
the peptides are largely in random coil secondary structure
(data not shown). The presence of buffer ions (Fig. 4a) induces
a somewhat higher degree of secondary structure in melittin (a-
helix), mPrPp and bPrPp (h-sheet), but not in pAntp.
In the presence of neutral LUVs (Fig. 4b), the peptides,
except for pAntp, become more structured. With its low
hydrophobicity (Table 1), pAntp has a low binding affinity to
an electrically neutral membrane [39,48], and hence remains
unstructured. Introduction of charges (30%) to the LUV surface
induces some a-helical structure in pAntp, whereas mPrPp and
bPrPp increase their h-structure contributions to some extent
(Fig. 4c; Table 2). Melittin, on the other hand, maintains the
same high degree of helicity (Fig. 4c).
3.5. Vesicle aggregation due to pAntp
In the presence of partially charged vesicles, pAntp
adopts a helical structure, and is generally Fbenign_, with
Fig. 3. The fluorescence intensity autocorrelation functions, G(s), of: (a) free rhodamine (Rh) in solution; (b) rhodamine-entrapping LUVS (REVs); and (c)
rhodamine-labeled LUVs (RLVs). The composition of the REVs and RLVs was POPG/POPC [30/70], with a total lipid concentration of 100 AM. The effect of the
peptides on the REVs, following incubation period of 1 hr: fluorescence intensity autocorrelation function G(s) of 100 AM REVs in the presence of : (d) 5 AM
melittin (P/L=0.05); (e) 10 AM mPrPp (P/L=0.1); and (f) 10 AM bPrPp (P/L=0.1). The FCS parameters derived by fittings of the autocorrelation curves are
summarized in Table 3. The medium in all cases was 50 mM phosphate buffer (pH 7.4), and all spectra were recorded at an ambient temperature (20 -C).
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previously observed that in the presence of fully charged
vesicles, the peptide adopts a dominating h-structure,
particularly at high P/L, and has pronounced membrane
perturbation effects [40,48]. Here we use FCS, in tandem
with steady-state fluorescence techniques, to characterize the
interaction of pAntp with the fully charged POPG LUVs, incomparison with the partially charged POPG/POPC [30/70]
vesicles.
Fig. 5a shows evaluated diffusion times, sD, as a function of
P/L for the RLVs with the two surface charges. A large
increase in the RLV diffusion time for fully charged POPG
vesicles is observed in the presence of pAntp, even at low
peptide concentrations. This indicates a severe case of vesicle
Table 3
Summary of the FCS parameters derived from the intensity autocorrelation
functions G(s) of rhodamine (Rh)a
Sample Bound/entrapped Rh fraction Free Rh fraction N
sD (ms) % sD (ms) %
Rh only – – 0.07 100 3.2
+LUVs 7.4 30 0.07 70 2.4
RLVs only 8.4 100 – – 0.4
+melittin 8.4 98 0.07 2 0.5
+mPrPp 8.4 98 0.07 2 0.5
+bPrPp 8.4 99 0.07 1 0.4
+pAntp 8.4 99 0.07 1 0.4
REVs only 7.4 85 0.07 15 0.3
+melittin 7.4b 20 0.07 80 2.8
+mPrPp 7.4b 30 0.07 70 1.3
+bPrPp 7.4b 35 0.07 65 1.1
+pAntp 7.4b 80 0.07 20 0.3
a Given are the % fractions of Rh diffusing with the vesicles (entrapped in
POPG/POPC [30/70] REVs or covalently bound to POPG/POPC [30/70]
RLVs) or freely diffusing (non-bound) in the absence, or presence, of the
peptides. The rhodamine (Rh) concentration in solution was 200 nM. The
vesicles (with a phospholipid concentration of 100 AM for both REV and RLV
samples) and the peptides (at a concentration of 10 AM, i.e. P/L=0.1, except for
melittin, which was at 5 AM, P/L=0.05) were incubated for a period of 1 h. The
fraction (%) of Rh diffusing with a certain sD was calculated using a two-
component fitting of the autocorrelation curves.
b The sD for this component was fixed during the fitting procedure.
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small increase in sD was observed, and then only at the higher
peptide concentrations (P/L>0.1). Thus, under the conditions
of the experiments carried out with POPC and POPC/POPG
[30/70] LUVs in this study, vesicle aggregation does not occur.
LUV aggregation was also observed with POPG RLVs in the
presence of the prion peptides, and aggregation comparable to
that induced by pAntp was observed at the higher P/L values
(Fig. 5a).
Fig. 5b shows the FCS kinetics of the aggregation of POPG
RLVs in the presence of pAntp (P/L=0.05 and 0.1). With P/
L=0.05 only a partial aggregation is observed. The aggregation
process is completed within 5 min. Once aggregation takes
place, the aggregates are stable up to 24 h (Fig. 5b inset),
contrary to what has previously been reported from light
scattering studies, where gradual disaggregation was observed,
over a period of 1–2 h [49]. The higher degree of h-structure
induced in pAntp with the POPG LUVs than with the POPG/
POPC [30/70] LUVs (Table 2) was highly stable. We did not
detect any transient secondary structure conversion back to a-
helix under the present conditions.
Similar extreme properties of POPG LUVs with pAntp is
observed with steady-state fluorescence: a significant increase
in DPH polarization, and an increase in the calcein leakage
(Table 2). The total fraction of free Rh increases to 60% upon
addition of pAntp to POPG REVs (FCS data not shown).Fig. 4. CD Spectra of 4 AM of mPrPp (—), bPrPp (- - -), pAntp (– – ) and
melittin (–˝– ) in different media: (a) 50 mM phosphate buffer, and LUVs
composed of (b) 100 AM POPC, or (c) 100 AM POPG/POPC [30/70]. The
medium for the LUVs was 50 mM phosphate buffer (pH 7.4). The temperature
was set at 20 -C.
Fig. 5. LUV aggregation due to the peptides as determined by the diffusion
times obtained by FCS. (a) pAntp induced aggregation of POPG/POPC [30/70]
RLVs (o) and POPG RLVs (.). Also shown is the aggregation of POPG RLVs
due to mPrPp (r) and bPrPp (4). Increasing concentrations of the peptides
were added to the RLV samples, at a 100-AM phospholipid concentration, and
containing 0.1 mol% Rh-labeled lipids. The diffusion time of the RLVs was
plotted as a function of P/L. (b) Time-dependence of pAntp induced PG RLV
aggregation, at P/L=0.10 (˝) and P/L=0.05 (g). Inset: longer time-scale of the
same measurement. The medium was 50 mM phosphate buffer (pH 7.4). The
spectra were recorded at an ambient temperature (20 -C).
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and leakage are related for pAntp, where a high membrane
surface charge promotes a large surface occupancy and
concomitant h-structure promotion in the peptide.
4. Discussion
The present study focuses on the N-terminal signal peptide
with an additional short basic domain of mouse and bovine
unprocessed PrPs. The two prion peptides, mPrPp [21] and
bPrPp (Magzoub et al., unpublished results), were previously
found to function as cell-penetrating peptides (CPPs). In
general, the low cytotoxic effects of typical CPPs, such as
pAntp and the HIV-1 Tat peptide, distinguish them from
translocating cationic antimicrobial and pore-forming peptides,
such as melittin, which exhibit strong effects on the membraneintegrity. However, like certain CPPs, particularly the amphi-
pathic chimeras [22,23], the prion peptides produced membrane
perturbations in cells, resulting in morphological stress [20], as
well as hemolysis of red blood cells and leakage from CHO and
neuronal N2A cells (Magzoub et al., unpublished results).
We have now studied the membrane perturbation effects of
the prion-derived peptides in vesicle model systems, comparing
the results with those of the archetypal CPP pAntp, and the pore-
forming melittin. pAntp does not perturb the LUVs to any great
extent (Figs. 1 and 2; Tables 2 and 3). Melittin, on the other
hand, causes pronounced membrane disturbances. The peptide
induces maximal leakage of entrapped calcein, and causes
considerable release of Rh from the REVs (Figs. 1 and 3; Tables
2 and 3). Leakage from the LUVs can be caused either by
completely destroying the vesicles (lysis) or by making chan-
nels into them (pore-formation). As the translational properties
of the RLVs remain constant in the presence of melittin, under
conditions where leakage from the REVs was observed in terms
of P/L (Table 3), and an increase in membrane ordering is
observed (Fig. 2), we conclude that pore-formation rather than
lysis is the explanation for the observed effects. This agrees with
numerous literature reports on melittin [38,46,47,50].
The two prion peptides, mPrPp and bPrPp, behave
similarly to melittin, giving rise to substantial leakage of
the vesicle contents (Figs. 1 and 3; Tables 2 and 3). The
overall integrity of the vesicles is not affected, as indicated by
the unchanged diffusion times of the RLVs (Table 3). This
again suggests pore-formation caused by mPrPp and bPrPp. It
is worth noting here that there is at present no consensus on
the definition of the Fpore_. While some reports use the term
to describe a defined structure, composed of a number of
helices in a parallel alignment, others use it to describe a
peptide-induced structural defect in the membrane through
which ions or molecules can pass [38,51]. In the present
context, we use the latter, broader definition. The orientation
of melittin in lipid bilayers is dependent on a number of
parameters, including P/L and lipid type. At the relatively
high concentrations used here it is likely that melittin adopts a
transmembrane orientation [52]. In an NMR study of bPrPp
associated with neutral DHPC micelles [20], the results
indicated that the induced a-helical structure observed under
those conditions should have a transmembrane orientation, a
positioning favouring pore-formation.
The kinetics of peptide-induced calcein leakage exhibits
saturation (Fig. 1b). Such phenomena have been observed in
several other studies of peptides interacting with membranes,
yielding leakage curves which reach a plateau as a function of
time at a constant peptide concentration [53–55]. The
observations have been interpreted in terms of transient pore
formation, involving a nucleation step during an initial bilayer
perturbation period, followed by a transient restabilization of
the peptide/lipid bilayer structure, which gives rise to the
observed leveling off of the spontaneous leakage [56]. The
saturation of the leakage curves for mPrPp and bPrPp as a
function of peptide concentration (Fig. 1) may have a similar
background. Alternatively, this behavior could be due to
increased self-aggregation of the prion peptides taking place
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lished results) resulting in attenuation of peptide activity.
The two prion peptides differ from melittin in that a higher
membrane surface charge density leads to a greater effect on
the membrane integrity. At the higher LUV surface charge
density the peptides, with higher h-structure content (possibly
in an aggregated state), have a more potent effect on the
membrane integrity than observed with neutral membranes.
This suggests that peptide aggregation and concomitant h-
structure induction may be one prerequisite for pore-formation
caused by the prion peptides.
When interacting with fully charged LUVs, pAntp adopts a
h-structure [48] and causes vesicle aggregation and leakage
(Fig. 5; Table 2). The high charge density of the fully charged
LUVs promotes extreme behavior in both the vesicles and the
peptides. The high surface charge density may lead to peptide
aggregation (manifesting itself as h-structure), which in turn
leads to vesicle aggregation. This could explain the increase in
membrane DPH polarization observed here with fully charged
LUVs (Table 2), as well as the previously reported large
increase in the DPH polarization with the fully charged SUVs
induced by pAntp [40]. The h-structure and vesicle aggrega-
tion are not completely interdependent, since we observe some
h-structure even when there is no obvious vesicle aggregation
(data not shown).
In this study, we have attempted to complement the
traditional calcein release assay with a more novel release
assay using FCS. Although the parameters measured in both
cases are different—fluorescence Fde-quenching_ as opposed to
translational diffusion—while the concentration gradients
involved are also rather different, the two methods obviously
give similar and complementary results.
Calcein-release is an established method. Self-quenching of
calcein has been attributed to a combination of dimerization
and energy transfer [57]. However, the high concentrations of
the entrapped calcein used (¨55–70 mM) is problematic. For
instance, at higher prion peptide concentrations, a decrease in
the calcein fluorescence intensity was observed (data not
shown). This might be due to self-quenching of the released
calcein, and/or binding of the negatively charged calcein to the
basic peptides (which also have a high propensity to aggregate)
leading to formation of large peptide–calcein complexes,
which results in further quenching of the calcein quantum
yield. Such phenomena can distort the analysis.
With FCS, and the low concentrations of Rh required (in the
nM range), this problem is mostly avoided. However, the
affinity of Rh for phospholipids complicates the analysis (Table
3), suggesting the need for an alternative fluorophore. In
addition, the presence of two forms of fluorescent particles
with very different fluorescence intensities (in this case, Rh free
in solution and Rh entrapped in the REVs) distort the
quantitative evaluations [45].
The long N-terminal part of the PrP sequence is unstruc-
tured in aqueous solution [7]. The interaction of the signal
peptide-containing domain with a membrane mediates second-
ary structure conversion towards h-sheet for the domain.
Perhaps, this moiety can serve as a Fseed_ for a structureconversion involving a larger part of the unprocessed PrP,
possibly taking place at a membrane surface. A membrane-
induced structure conversion in the N-terminus may also be
important for the transformation from PrPC to PrPSc. The
membrane-induced aggregation and structure conversion may
be a common process for several amyloid forming proteins and
peptides, as a general phenomenon leading to toxic effects in
cellular systems (cf. [58,59]). Among the common amyloid
proteins [58], only the unprocessed PrP has a hydrophobic
signal sequence directly followed by a basic sequence, the
combination of which is related to the CPP property of the N-
terminal domain. This inherent property may facilitate inter-
cellular prion trafficking, and furthermore contribute to the
membrane perturbations, as observed in this study.
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